SG11202001868RA - Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n-benzylacetamide - Google Patents
Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n-benzylacetamideInfo
- Publication number
- SG11202001868RA SG11202001868RA SG11202001868RA SG11202001868RA SG11202001868RA SG 11202001868R A SG11202001868R A SG 11202001868RA SG 11202001868R A SG11202001868R A SG 11202001868RA SG 11202001868R A SG11202001868R A SG 11202001868RA SG 11202001868R A SG11202001868R A SG 11202001868RA
- Authority
- SG
- Singapore
- Prior art keywords
- benzylacetamide
- morpholinoethoxy
- pyridin
- phenyl
- solid forms
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyridine Compounds (AREA)
- Physics & Mathematics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- Crystallography & Structural Chemistry (AREA)
- General Physics & Mathematics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762555390P | 2017-09-07 | 2017-09-07 | |
| PCT/US2018/049829 WO2019051147A1 (en) | 2017-09-07 | 2018-09-07 | Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n-benzylacetamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11202001868RA true SG11202001868RA (en) | 2020-03-30 |
Family
ID=65517772
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11202001868RA SG11202001868RA (en) | 2017-09-07 | 2018-09-07 | Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n-benzylacetamide |
Country Status (13)
| Country | Link |
|---|---|
| US (3) | US10669236B2 (en) |
| EP (1) | EP3679016A4 (en) |
| JP (2) | JP2020533412A (en) |
| KR (1) | KR20200081359A (en) |
| CN (1) | CN111278808B (en) |
| AU (2) | AU2018330163B2 (en) |
| BR (1) | BR112020004419A2 (en) |
| CA (1) | CA3074831A1 (en) |
| IL (1) | IL272992A (en) |
| MX (2) | MX2020002622A (en) |
| SG (1) | SG11202001868RA (en) |
| TW (1) | TWI815820B (en) |
| WO (1) | WO2019051147A1 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7968574B2 (en) * | 2004-12-28 | 2011-06-28 | Kinex Pharmaceuticals, Llc | Biaryl compositions and methods for modulating a kinase cascade |
| EP4186890A1 (en) | 2021-11-29 | 2023-05-31 | Moehs Ibérica, S.L. | Preparation of n-benzyl-2-(5-bromo-pyridin-2-yl)-acetamide for the synthesis of tirbanibulin |
| CN115010655A (en) * | 2022-07-21 | 2022-09-06 | 重庆迈德凯医药有限公司 | Purification method of tinib bulin |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| CA2594345C (en) | 2004-12-28 | 2013-11-05 | Kinex Pharmaceuticals, Llc | Compositions and methods of treating cell proliferation disorders |
| ES2500165T3 (en) * | 2006-06-29 | 2014-09-30 | Kinex Pharmaceuticals, Llc | Biaryl compositions and methods to modulate a kinase cascade |
| US7935697B2 (en) | 2006-12-28 | 2011-05-03 | Kinex Pharmaceuticals, Llc | Compositions for modulating a kinase cascade and methods of use thereof |
| TWI457336B (en) | 2006-12-28 | 2014-10-21 | Kinex Pharmaceuticals Llc | Composition and methods for modulating a kinase cascade |
| US7939529B2 (en) | 2007-05-17 | 2011-05-10 | Kinex Pharmaceuticals, Llc | Process for the preparation of compositions for modulating a kinase cascade and methods of use thereof |
| WO2015069217A1 (en) * | 2013-11-05 | 2015-05-14 | Baylor College Of Medicine | Src kinase inhibition as treatment for lympangioleiomyomatosis and tuberous sclerosis |
| CN106810490A (en) * | 2017-02-06 | 2017-06-09 | 重庆泰润制药有限公司 | A kind of crystal formation of biaryl compound and its preparation method and application |
-
2018
- 2018-09-07 CA CA3074831A patent/CA3074831A1/en active Pending
- 2018-09-07 WO PCT/US2018/049829 patent/WO2019051147A1/en unknown
- 2018-09-07 TW TW107131540A patent/TWI815820B/en active
- 2018-09-07 KR KR1020207010105A patent/KR20200081359A/en active IP Right Grant
- 2018-09-07 BR BR112020004419-9A patent/BR112020004419A2/en unknown
- 2018-09-07 JP JP2020536496A patent/JP2020533412A/en active Pending
- 2018-09-07 CN CN201880069894.6A patent/CN111278808B/en active Active
- 2018-09-07 US US16/124,281 patent/US10669236B2/en active Active
- 2018-09-07 EP EP18854688.1A patent/EP3679016A4/en active Pending
- 2018-09-07 AU AU2018330163A patent/AU2018330163B2/en active Active
- 2018-09-07 SG SG11202001868RA patent/SG11202001868RA/en unknown
- 2018-09-07 MX MX2020002622A patent/MX2020002622A/en unknown
-
2020
- 2020-03-01 IL IL272992A patent/IL272992A/en unknown
- 2020-03-06 MX MX2023001805A patent/MX2023001805A/en unknown
- 2020-04-27 US US16/858,854 patent/US11230527B2/en active Active
-
2021
- 2021-12-09 US US17/546,133 patent/US20220098152A1/en active Pending
-
2023
- 2023-02-21 AU AU2023201010A patent/AU2023201010A1/en active Pending
- 2023-06-30 JP JP2023107781A patent/JP2023157909A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20200255380A1 (en) | 2020-08-13 |
| CA3074831A1 (en) | 2019-03-14 |
| US20190071402A1 (en) | 2019-03-07 |
| TW201920160A (en) | 2019-06-01 |
| AU2018330163B2 (en) | 2023-02-02 |
| AU2018330163A1 (en) | 2020-03-26 |
| IL272992A (en) | 2020-04-30 |
| JP2023157909A (en) | 2023-10-26 |
| CN111278808B (en) | 2024-04-26 |
| US10669236B2 (en) | 2020-06-02 |
| KR20200081359A (en) | 2020-07-07 |
| AU2023201010A1 (en) | 2023-03-23 |
| BR112020004419A2 (en) | 2020-09-08 |
| JP2020533412A (en) | 2020-11-19 |
| EP3679016A1 (en) | 2020-07-15 |
| CN111278808A (en) | 2020-06-12 |
| US11230527B2 (en) | 2022-01-25 |
| WO2019051147A1 (en) | 2019-03-14 |
| MX2023001805A (en) | 2023-03-13 |
| RU2020112539A3 (en) | 2022-04-19 |
| RU2020112539A (en) | 2021-10-08 |
| MX2020002622A (en) | 2020-10-01 |
| TWI815820B (en) | 2023-09-21 |
| US20220098152A1 (en) | 2022-03-31 |
| EP3679016A4 (en) | 2021-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL280572A (en) | 2-(het)aryl-substituted condensed heterocyclic derivatives as pest control agents | |
| IL283333A (en) | New heterocyclic compounds | |
| IL279910A (en) | Crystalline forms of 5-chloro-n4-[2-(dimethylphosphoryl)phenyl]-n2- {2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine | |
| IL272992A (en) | Solid forms of 2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-n-benzylacetamide | |
| IL260908B (en) | Substituted 2-(het)aryl-imidazolyl-carboxyamides as pest control agents | |
| HK1255438A1 (en) | (s,e)-3-(6-aminopyridin-3-yl)-n-((5-(4-(3-fluoro-3-methylpyrrolidine-1-carbonyl)phenyl)-7-(4-fluorophenyl)benzofuran-2-yl)methyl)acrylamide for the treatment of cancer | |
| EP3376865A4 (en) | 4-((6-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(1h | |
| ZA201804482B (en) | Formulations of 2-(4-chlorophenyl)-n-((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-5-yl)methyl)-2,2-difluoroacetamide | |
| IL256237A (en) | Solid forms of (z)-4-(5-((3-benzyl-4-oxo-2-thioxothiazolidin-5-ylidene)methyl)furan-2-yl)benzoic acid | |
| IL279977A (en) | Anthelminthic heterocyclic compounds | |
| SI3658547T1 (en) | Process for preparing n-(5-(4-(4-formyl-3-phenyl-1h-pyrazol-1-yl)pyrimidin-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide | |
| SI3298008T1 (en) | Crystalline form of the compound (s)-3-(4-(5-(2-cyclopentyl-6-methoxy-pyridin-4-yl)-(1,2,4)oxadiazol-3-yl)-2-ethyl-6-methyl-phenoxy)-propane-1,2-diol | |
| DK3559010T3 (en) | PROCEDURE FOR THE PREPARATION OF 5-[[4-[2-[5-(1-HYDROXYETHYL)-2-PYRIDINYL]ETHOXY]PHENYL]METHYL]-2,4-THIAZOLIDINEDION AND ITS SALTS | |
| DK3853219T3 (en) | HERBICIDELY ACTIVE SUBSTITUTED PHENYL PYRIMIDINE HYDRAZIDES | |
| SG11202004891PA (en) | Novel use of 3-(4-(benzyloxy)phenyl)hex-4-inoic acid derivative | |
| NZ716494A (en) | Processes and intermediates for the preparation of a pde10 inhibitor | |
| EP3541797A4 (en) | 4-((6-(2-(2,4-difluorophenyl)-1,1-difluoro-2-hydroxy-3-(5-mercapto-1h | |
| RS58961B1 (en) | Process for the production of 2-[4-(cyclopropanecarbonyl)phenyl]-2-methyl-propanenitrile | |
| SG11202104857PA (en) | Heterocyclic spiro-compounds as am2 receptor inhibitors | |
| SG11202104883TA (en) | Heterocyclic spiro-compounds as am2 receptor inhibitors | |
| EP3529243C0 (en) | (z)-3-(2-(5-bromo-1h-indol-3-yl)-2-cyanovinyl)-4-methoxybenzonitrile for the treatment of endometriosis | |
| GB201808580D0 (en) | Heterocyclic compounds | |
| GB201806488D0 (en) | Heterocyclic TADF compounds | |
| UA98919U (en) | 4-ethyl3-(phenoxymethyl)-5-((2-((5-phenoxymethyl)-4-phenyl-4h-1,2,4-triazole-3-il)thio)ethyl)thio)-4h-1,2,4-triazole, exhibiting diuretic activity | |
| UA97377U (en) | 3 - ((2-chloroethyl) thio) -5- (3,4,5-trimethoxyphenyl) -1h-1,2,4-triazole which exhibits hypoglycemic activity |